Abbruzzese, J L <br/><br/>
A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity.  [electronic resource] 

 -  Journal of biological response modifiers  Oct 1990 
 - 522-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-6580 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Drug Evaluation<br/>Female<br/>Gastrointestinal Neoplasms--drug therapy<br/>Humans<br/>Interferon-gamma--administration & dosage<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Severity of Illness Index<br/>Tumor Necrosis Factor-alpha--administration & dosage